AAAAAA

   
Results: 1-21 |
Results: 21
IMPACT OF EXOGENOUS GROWTH-FACTORS ON PROLIFERATION AND CHEMOSENSITIVITY OF MINIMAL RESIDUAL ACUTE MYELOID-LEUKEMIA
Authors: GORE SD BURKE PJ WENG LJ
Citation: Sd. Gore et al., IMPACT OF EXOGENOUS GROWTH-FACTORS ON PROLIFERATION AND CHEMOSENSITIVITY OF MINIMAL RESIDUAL ACUTE MYELOID-LEUKEMIA, Leukemia & lymphoma, 29(3-4), 1998, pp. 339-350
PHARMACOKINETICS OF MEDROXYPROGESTERONE ACETATE AFTER SINGLE AND MULTIPLE INJECTION OF CYCLOFEM(R) IN CHINESE WOMEN
Authors: ZHOU XF SHAO QX HAN XJ WENG LJ SANG GW
Citation: Xf. Zhou et al., PHARMACOKINETICS OF MEDROXYPROGESTERONE ACETATE AFTER SINGLE AND MULTIPLE INJECTION OF CYCLOFEM(R) IN CHINESE WOMEN, Contraception, 57(6), 1998, pp. 405-411
IMPACT OF THE PUTATIVE DIFFERENTIATING AGENTS SODIUM PHENYLBUTYRATE AND SODIUM PHENYLACETATE ON PROLIFERATION, DIFFERENTIATION, AND APOPTOSIS OF PRIMARY NEOPLASTIC MYELOID CELLS
Authors: GORE SD SAMID D WENG LJ
Citation: Sd. Gore et al., IMPACT OF THE PUTATIVE DIFFERENTIATING AGENTS SODIUM PHENYLBUTYRATE AND SODIUM PHENYLACETATE ON PROLIFERATION, DIFFERENTIATION, AND APOPTOSIS OF PRIMARY NEOPLASTIC MYELOID CELLS, Clinical cancer research, 3(10), 1997, pp. 1755-1762
SYNERGY BETWEEN RETINOIC ACID (IU) AND THE PUTATIVE DIFFERENTIATING AGENT SODIUM PHENYLBUTYRATE (SPB) PROMOTES MAXIMAL CYTOSTASIS AND DIFFERENTIATION OF MYELOID CELLS AT CLINICALLY ACHIEVABLE DOSES OF SPB
Authors: WENG LJ YU K FU S GORE SD
Citation: Lj. Weng et al., SYNERGY BETWEEN RETINOIC ACID (IU) AND THE PUTATIVE DIFFERENTIATING AGENT SODIUM PHENYLBUTYRATE (SPB) PROMOTES MAXIMAL CYTOSTASIS AND DIFFERENTIATION OF MYELOID CELLS AT CLINICALLY ACHIEVABLE DOSES OF SPB, Blood, 90(10), 1997, pp. 1469-1469
GROWTH-FACTOR MODULATION OF P21(WAF1 CIP1) IN PRIMARY ACUTE MYELOID LEUKEMIAS/
Authors: DIGIUSEPPE JA GORE SD WENG LJ KASTAN MB
Citation: Ja. Digiuseppe et al., GROWTH-FACTOR MODULATION OF P21(WAF1 CIP1) IN PRIMARY ACUTE MYELOID LEUKEMIAS/, Blood, 88(10), 1996, pp. 331-331
IMPROVED HEMATOPOIESIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML) FOLLOWING ADMINISTRATION OF THE PUTATIVE DIFFERENTIATING AGENT SODIUM PHENYLBURYRATE (SPB)
Authors: GORE SD MILLER CB WENG LJ BURKS K GRIFFIN CA CHEN TL BURKE PJ GREVER M ROWINSKY EK
Citation: Sd. Gore et al., IMPROVED HEMATOPOIESIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML) FOLLOWING ADMINISTRATION OF THE PUTATIVE DIFFERENTIATING AGENT SODIUM PHENYLBURYRATE (SPB), Blood, 88(10), 1996, pp. 2315-2315
IMPACT OF IN-VIVO ADMINISTRATION OF INTERLEUKIN-3 ON PROLIFERATION, DIFFERENTIATION, AND CHEMOSENSITIVITY OF ACUTE MYELOID-LEUKEMIA
Authors: GORE SD WENG LJ JONES RJ COWAN K ZILCHA M PIANTADOSI S BURKE PJ
Citation: Sd. Gore et al., IMPACT OF IN-VIVO ADMINISTRATION OF INTERLEUKIN-3 ON PROLIFERATION, DIFFERENTIATION, AND CHEMOSENSITIVITY OF ACUTE MYELOID-LEUKEMIA, Clinical cancer research, 1(3), 1995, pp. 295-303
STEEL FACTOR SUPPORTS THE CYCLING OF ISOLATED HUMAN CD34(-FACTORS() CELLS IN THE ABSENCE OF OTHER GROWTH)
Authors: GORE SD AMIN S WENG LJ CIVIN CI
Citation: Sd. Gore et al., STEEL FACTOR SUPPORTS THE CYCLING OF ISOLATED HUMAN CD34(-FACTORS() CELLS IN THE ABSENCE OF OTHER GROWTH), Experimental hematology, 23(5), 1995, pp. 413-421
FACTOR STRUCTURE OF THE PASS COGNITIVE TASKS - A REEXAMINATION OF NAGLIERI ET-AL (1991)
Authors: KRANZLER JH WENG LJ
Citation: Jh. Kranzler et Lj. Weng, FACTOR STRUCTURE OF THE PASS COGNITIVE TASKS - A REEXAMINATION OF NAGLIERI ET-AL (1991), Journal of school psychology, 33(2), 1995, pp. 143-157
FACTOR STRUCTURE OF A BATTERY OF PASS COGNITIVE TASKS - REPLY
Authors: KRANZLER JH WENG LJ
Citation: Jh. Kranzler et Lj. Weng, FACTOR STRUCTURE OF A BATTERY OF PASS COGNITIVE TASKS - REPLY, Journal of school psychology, 33(2), 1995, pp. 169-176
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (CM-CSF), GIVEN CONCURRENTLY WITH INDUCTION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML), AUGMENTS THE SYNDROME OF T-LYMPHOCYTE RECOVERY
Authors: GORE SD DONNENBERG AD ZEHNBAUER BA WENG LJ BURKE PJ
Citation: Sd. Gore et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (CM-CSF), GIVEN CONCURRENTLY WITH INDUCTION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML), AUGMENTS THE SYNDROME OF T-LYMPHOCYTE RECOVERY, Leukemia, 8(3), 1994, pp. 409-419
IDENTIFICATION OF GROWTH FACTOR-RESPONSIVE ACUTE MYELOGENOUS LEUKEMIABASED ON FACTOR-DEPENDENCE FOR SURVIVAL AND PROLIFERATION
Authors: GORE SD WENG LJ BURKE PJ
Citation: Sd. Gore et al., IDENTIFICATION OF GROWTH FACTOR-RESPONSIVE ACUTE MYELOGENOUS LEUKEMIABASED ON FACTOR-DEPENDENCE FOR SURVIVAL AND PROLIFERATION, Leukemia, 8(11), 1994, pp. 1854-1863
WILL GROWTH-FACTOR AUGMENTATION DURING POSTREMISSION THERAPY FOR AML OVERCOME DRUG-RESISTANCE
Authors: WENG LJ BURKE PJ GORE SD
Citation: Lj. Weng et al., WILL GROWTH-FACTOR AUGMENTATION DURING POSTREMISSION THERAPY FOR AML OVERCOME DRUG-RESISTANCE, Experimental hematology, 22(8), 1994, pp. 772-772
WHAT IS A GOOD G
Authors: JENSEN AR WENG LJ
Citation: Ar. Jensen et Lj. Weng, WHAT IS A GOOD G, Intelligence, 18(3), 1994, pp. 231-258
MAXIMAL AND NEAR-MAXIMAL SHIFT REGISTER SEQUENCES - EFFICIENT EVENT COUNTERS AND EASY DISCRETE LOGARITHMS
Authors: CLARK DW WENG LJ
Citation: Dw. Clark et Lj. Weng, MAXIMAL AND NEAR-MAXIMAL SHIFT REGISTER SEQUENCES - EFFICIENT EVENT COUNTERS AND EASY DISCRETE LOGARITHMS, I.E.E.E. transactions on computers, 43(5), 1994, pp. 560-568
TERMINATION OF EARLY-PREGNANCY BY 2 REGIMENS OF MIFEPRISTONE WITH MISOPROSTOL AND MIFEPRISTONE WITH PG05 - A MULTICENTER RANDOMIZED CLINICAL-TRIAL IN CHINA
Authors: SANG GW WENG LJ SHAO QX DU MK WU XZ LU YI CHENG LN
Citation: Gw. Sang et al., TERMINATION OF EARLY-PREGNANCY BY 2 REGIMENS OF MIFEPRISTONE WITH MISOPROSTOL AND MIFEPRISTONE WITH PG05 - A MULTICENTER RANDOMIZED CLINICAL-TRIAL IN CHINA, Contraception, 50(6), 1994, pp. 501-510
AN EPIDEMIOLOGIC-STUDY ON THE RELATIONSHIP OF ECTOPIC PREGNANCY AND THE USE OF CONTRACEPTIVES IN BEIJING - THE INCIDENCE OF ECTOPIC PREGNANCY IN THE BEIJING AREA
Authors: ZHANG ZM WENG LJ ZHANG ZY JIN XX JING XP ZHANG LY LIAN SH CUI YB
Citation: Zm. Zhang et al., AN EPIDEMIOLOGIC-STUDY ON THE RELATIONSHIP OF ECTOPIC PREGNANCY AND THE USE OF CONTRACEPTIVES IN BEIJING - THE INCIDENCE OF ECTOPIC PREGNANCY IN THE BEIJING AREA, Contraception, 50(3), 1994, pp. 253-262
BIOLOGIC AND CLINICAL IMPACT OF GROWTH-FACTOR (GF) AUGMENTATION OF POSTREMISSION CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA (AML)
Authors: GORE SD WENG LJ BURKE PJ
Citation: Sd. Gore et al., BIOLOGIC AND CLINICAL IMPACT OF GROWTH-FACTOR (GF) AUGMENTATION OF POSTREMISSION CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA (AML), Blood, 84(10), 1994, pp. 10000582-10000582
IRREVERSIBLE INHIBITION OF PROLIFERATION OF PRIMARY ACUTE MYELOID LEUKEMIC (AML) CELLS BY PHENYL BUTYRATE (PB)
Authors: WENG LJ SAMID D BURKE PJ GORE SD
Citation: Lj. Weng et al., IRREVERSIBLE INHIBITION OF PROLIFERATION OF PRIMARY ACUTE MYELOID LEUKEMIC (AML) CELLS BY PHENYL BUTYRATE (PB), Blood, 84(10), 1994, pp. 10000628-10000628
VALIDATION OF FLOW-CYTOMETRIC DETERMINATION OF KI67 EXPRESSION AS A MEASURE OF GROWTH-FACTOR RESPONSE IN ACUTE MYELOGENOUS LEUKEMIA
Authors: GORE SD WENG LJ BURKE PJ
Citation: Sd. Gore et al., VALIDATION OF FLOW-CYTOMETRIC DETERMINATION OF KI67 EXPRESSION AS A MEASURE OF GROWTH-FACTOR RESPONSE IN ACUTE MYELOGENOUS LEUKEMIA, Experimental hematology, 21(13), 1993, pp. 1702-1708
IN-VIVO ADMINISTRATION OF INTERLEUKIN-3 (IL-3) DURING REMISSION INDUCTION THERAPY FOR AML - PLEIOTROPIC EFFECTS ON DRUG-SENSITIVITY
Authors: GORE SD JONES RJ WENG LJ COWAN K JOHNSON MC ZILCHA M BURKE PJ
Citation: Sd. Gore et al., IN-VIVO ADMINISTRATION OF INTERLEUKIN-3 (IL-3) DURING REMISSION INDUCTION THERAPY FOR AML - PLEIOTROPIC EFFECTS ON DRUG-SENSITIVITY, Blood, 82(10), 1993, pp. 10000443-10000443
Risultati: 1-21 |